These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


270 related items for PubMed ID: 9989450

  • 21. Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B.
    Catania MG, Mischel PS, Vinters HV.
    J Neuropathol Exp Neurol; 2001 Jul; 60(7):711-23. PubMed ID: 11444800
    [Abstract] [Full Text] [Related]

  • 22. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.
    Gutmann DH, Zhang Y, Hasbani MJ, Goldberg MP, Plank TL, Petri Henske E.
    Acta Neuropathol; 2000 Mar; 99(3):223-30. PubMed ID: 10663963
    [Abstract] [Full Text] [Related]

  • 23. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
    Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE.
    Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
    [Abstract] [Full Text] [Related]

  • 24. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin.
    Nellist M, van Slegtenhorst MA, Goedbloed M, van den Ouweland AM, Halley DJ, van der Sluijs P.
    J Biol Chem; 1999 Dec 10; 274(50):35647-52. PubMed ID: 10585443
    [Abstract] [Full Text] [Related]

  • 25. Differential localization of hamartin and tuberin and increased S6 phosphorylation in a tuber.
    Jansen FE, Notenboom RG, Nellist M, Goedbloed MA, Halley DJ, de Graan PN, van Nieuwenhuizen O.
    Neurology; 2004 Oct 12; 63(7):1293-5. PubMed ID: 15477556
    [Abstract] [Full Text] [Related]

  • 26. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology.
    Crino PB, Trojanowski JQ, Dichter MA, Eberwine J.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):14152-7. PubMed ID: 8943076
    [Abstract] [Full Text] [Related]

  • 27. The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
    Mak BC, Takemaru K, Kenerson HL, Moon RT, Yeung RS.
    J Biol Chem; 2003 Feb 21; 278(8):5947-51. PubMed ID: 12511557
    [Abstract] [Full Text] [Related]

  • 28. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
    Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J.
    Proc Natl Acad Sci U S A; 2002 Oct 15; 99(21):13571-6. PubMed ID: 12271141
    [Abstract] [Full Text] [Related]

  • 29. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
    Jóźwiak S, Kwiatkowski D, Kotulska K, Larysz-Brysz M, Lewin-Kowalik J, Grajkowska W, Roszkowski M.
    J Child Neurol; 2004 Feb 15; 19(2):102-6. PubMed ID: 15072102
    [Abstract] [Full Text] [Related]

  • 30. Proteins interacting with the tuberous sclerosis gene products.
    Rosner M, Freilinger A, Hengstschläger M.
    Amino Acids; 2004 Oct 15; 27(2):119-28. PubMed ID: 15351877
    [Abstract] [Full Text] [Related]

  • 31. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ.
    J Neuropathol Exp Neurol; 2004 Dec 15; 63(12):1236-42. PubMed ID: 15624760
    [Abstract] [Full Text] [Related]

  • 32. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S.
    Folia Neuropathol; 2008 Dec 15; 46(1):43-8. PubMed ID: 18368626
    [Abstract] [Full Text] [Related]

  • 33. Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.
    Lugnier C, Majores M, Fassunke J, Pernhorst K, Niehusmann P, Simon M, Nellist M, Schoch S, Becker A.
    J Neuropathol Exp Neurol; 2009 Oct 15; 68(10):1136-46. PubMed ID: 19918125
    [Abstract] [Full Text] [Related]

  • 34. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.
    Boer K, Troost D, Jansen F, Nellist M, van den Ouweland AM, Geurts JJ, Spliet WG, Crino P, Aronica E.
    Neuropathology; 2008 Dec 15; 28(6):577-90. PubMed ID: 18410267
    [Abstract] [Full Text] [Related]

  • 35. Biallelic TSC gene inactivation in tuberous sclerosis complex.
    Crino PB, Aronica E, Baltuch G, Nathanson KL.
    Neurology; 2010 May 25; 74(21):1716-23. PubMed ID: 20498439
    [Abstract] [Full Text] [Related]

  • 36. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
    Nellist M, Goedbloed MA, Halley DJ.
    Biochem Soc Trans; 2003 Jun 25; 31(Pt 3):587-91. PubMed ID: 12773161
    [Abstract] [Full Text] [Related]

  • 37. Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin.
    Yamamoto Y, Jones KA, Mak BC, Muehlenbachs A, Yeung RS.
    Arch Biochem Biophys; 2002 Aug 15; 404(2):210-7. PubMed ID: 12147258
    [Abstract] [Full Text] [Related]

  • 38. Tuberous sclerosis complex: molecular pathogenesis and animal models.
    Piedimonte LR, Wailes IK, Weiner HL.
    Neurosurg Focus; 2006 Jan 15; 20(1):E4. PubMed ID: 16459994
    [Abstract] [Full Text] [Related]

  • 39. The TSC1 gene product, hamartin, negatively regulates cell proliferation.
    Miloloza A, Rosner M, Nellist M, Halley D, Bernaschek G, Hengstschläger M.
    Hum Mol Genet; 2000 Jul 22; 9(12):1721-7. PubMed ID: 10915759
    [Abstract] [Full Text] [Related]

  • 40. Tumour suppressors hamartin and tuberin: intracellular signalling.
    Krymskaya VP.
    Cell Signal; 2003 Aug 22; 15(8):729-39. PubMed ID: 12781866
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.